Cargando…

Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data

INTRODUCTION: Recombinant human growth hormone (rhGH) is effective and safe when used to treat growth hormone deficiency (GHD) in children. However, it has been suggested that switching between different types of rhGH can have a detrimental effect on patients. METHODS: The current analysis assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romer, Tomasz, Zabransky, Markus, Walczak, Mieczyslaw, Szalecki, Mieczyslaw, Balser, Sigrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873068/ https://www.ncbi.nlm.nih.gov/pubmed/24392295 http://dx.doi.org/10.1007/s13554-011-0004-8

Ejemplares similares

Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
por: Borrás Pérez, Maria Victoria, et al.
Publicado: (2017)

Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data
por: López-Siguero, Juan Pedro, et al.
Publicado: (2017)

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
por: Schwarz, Hans-Peter, et al.
Publicado: (2016)

One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
por: Schwarz, Hans-Peter, et al.
Publicado: (2014)

Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy
por: Lecka-Ambroziak, Agnieszka, et al.
Publicado: (2020)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

Dextrins from Maize Starch as Substances Activating the Growth of Bacteroidetes and Actinobacteria Simultaneously Inhibiting the Growth of Firmicutes, Responsible for the Occurrence of Obesity
por: Barczynska, Renata, et al.
Publicado: (2016)

Recombinant growth hormone therapy in a girl with costello syndrome: a 4-year observation
por: Blachowska, Ewa, et al.
Publicado: (2016)

Growth hormone improves short stature in children with Shwachman-Diamond syndrome
por: Bogusz-Wójcik, Agnieszka, et al.
Publicado: (2021)

Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age
por: Walczak, Mieczyslaw, et al.
Publicado: (2021)

Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study
por: Lecka-Ambroziak, Agnieszka, et al.
Publicado: (2021)

Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader–Willi Syndrome
por: Lecka-Ambroziak, Agnieszka, et al.
Publicado: (2021)

Assessment of insulin resistance in preterm children appropriate for gestational age versus term and preterm children with intrauterine growth restriction
por: Korpysz, Alicja, et al.
Publicado: (2021)

Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients
por: Schnabel, Dirk, et al.
Publicado: (2016)

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
por: Hou, Ling, et al.
Publicado: (2015)

Treatment challenges in pediatric Cushing’s disease: Review of the literature with particular emphasis on predictive factors for the disease recurrence
por: Pasternak-Pietrzak, Katarzyna, et al.
Publicado: (2019)

The quality of life in adult patients treated for Cushing’s disease in childhood
por: Pasternak-Pietrzak, Katarzyna, et al.
Publicado: (2021)

Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland
por: Glińska, Marta, et al.
Publicado: (2022)

Difficulties in Interpreting IGF-1 Levels in Short Stature Children Born Small for Gestational Age (SGA) Treated with Recombinant Human Growth Hormone (rhGH) Based on Data from Six Clinical Centers in Poland
por: Glińska, Marta, et al.
Publicado: (2023)

Forearm bone density, cross-sectional size and muscle cross-sectional area in adolescents with diabetes mellitus type 1 assessed by peripheral quantitative computed tomography
por: Jaworski, Maciej, et al.
Publicado: (2019)

Deficyt Kortyzolu, Jako Rzadka Przyczyna Cholestazy Niemowlęcej
por: Lipiński, Patryk, et al.
Publicado: (2018)

Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
por: Rapaport, Robert, et al.
Publicado: (2013)

The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+ Hematopoietic Cells from Children with Growth Hormone Deficiency
por: Kawa, Miłosz Piotr, et al.
Publicado: (2017)

Diabetic Retinopathy in Children with Type 1 Diabetes—Occurrence and Screening Using Optical Coherence Tomography
por: Wysocka-Mincewicz, Marta, et al.
Publicado: (2021)

Bacterial Microbiota and Fatty Acids in the Faeces of Overweight and Obese Children
por: BARCZYŃSKA, RENATA, et al.
Publicado: (2018)

Skeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes Mellitus
por: Wierzbicka, Elzbieta, et al.
Publicado: (2018)

Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope(®)): data from the PATRO Adults study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2020)

Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies
por: Luo, Xiaoping, et al.
Publicado: (2017)

Comparison of Frequency and Severity of Sleep-Related Breathing Disorders in Children with Simple Obesity and Paediatric Patients with Prader–Willi Syndrome
por: Lecka-Ambroziak, Agnieszka, et al.
Publicado: (2021)

Traditional and New Methods of Bone Age Assessment-An Overview
por: Prokop-Piotrkowska, Monika, et al.
Publicado: (2021)

Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
por: Lee, Ji-Eun, et al.
Publicado: (2019)

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2019)

Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
por: Rashid, Nazia, et al.
Publicado: (2014)

The Effects of Sampling Lateralization on Bilateral Inferior Petrosal Sinus Sampling for Pediatric Cushing’s Disease—A Single Endocrinology Centre Experience and Review of the Literature
por: Moszczyńska, Elzbieta, et al.
Publicado: (2021)

Pituitary stalk thickening in patients under 18 years of age - the most common causes and diagnostic procedures
por: Moszczyńska, Elżbieta, et al.
Publicado: (2022)

Permanent and transient congenital hypothyroidism in full-term and preterm born infants
por: Petriczko, Elżbieta, et al.
Publicado: (2013)

Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial
por: Sun, Chengjun, et al.
Publicado: (2021)

Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
por: Rashid, Nazia, et al.
Publicado: (2014)

Peripheral Neuropathy as a Complication of Diabetic Ketoacidosis in a Child with Newly Diagnosed Diabetes Type 1: A Case Report
por: Baszyńska-Wilk, Marta, et al.
Publicado: (2018)

Somatic development in children with Shwachman-Diamond syndrome
por: Bogusz-Wójcik, Agnieszka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8crfnq0uckcp88ptkv2l6pam4a